ARPA-H invests $62.7M in ADVOCATE program; UpDoc, Tempus AI & Atman Health to build FDA-authorized AI tools for heart disease care over 4 years.
UpDoc, Tempus AI and Atman Health will participate in a new program that aims to build FDA-authorized agentic AI tools to care for people with …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
ARPA-H launched ADVOCATE, funding UpDoc, Tempus AI & Atman Health to build FDA-authorized AI agents for heart failure treatment…
The Advanced Research Projects Agency for Health (ARPA-H) launched a $62.7 million effort to develop a patient-facing agentic…
The ARPA-H program could provide researchers with a roadmap to develop personalized gene editing drugs. Elsewhere, a Botox rival…
The American Diabetes Association's Innovation Fund Invests in UpDoc to Accelerate the Future of AI-Driven Chronic Disease…
In this week’s edition of InnovationRx, we look the billionaire dentist, Wegovy by subscription, Kailera’s planned IPO, and more.
The Angelman Syndrome Foundation is partnering with startup Citizen Health to offer families access to Ari, an artificial…
